Items where Division is "Current Faculties > Faculty of Medicine > Centre for Cancer Immunology" and Year is 2023
 | Up a level |
Number of items: 15.
Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation - Hannah Bauer-Smith, Abigail S.L. Sudol, Stephen A. Beers and Max Crispin
Type: Article
| 2023
A single bout of exercise enhances the efficacy of rituximab against autologous chronic lymphocytic leukaemia B cells ex vivo by transiently increasing natural killer cell frequency in blood, and simultaneously mobilises CD5 +CD19 +CD20 + B cells into blood - Harrison D. Collier-Bain, Annabelle Emery and Adam J. Causer
Type: Meeting abstract
| 2023
| Item not available on this server.
Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives - Osman Dadas, Ayse Ertay and Mark S. Cragg
Type: Review
| 2023
Special Issue “Advances in Genome Regulation in Cancer” - Jekaterina Erenpreisa, Alessandro Giuliani and Mark Steven Cragg
Type: Editorial
| 2023
XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression - Jack G. Fisher, Amber D.P. Doyle, Lara V. Graham, Shreyanshi Sonar, Ben Sale, Isla Henderson, Luis Del Rio, Peter W.M. Johnson, Yosef Landesman, Mark S. Cragg, Francesco Forconi, Christopher J. Walker, Salim I. Khakoo and Matthew D. Blunt
Type: Article
| 2023
Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunity - Paul T. Kennedy, Emma L. Saulters, Andrew D. Duckworth, Yeong Jer Lim, John F. Woolley, Joseph R. Slupsky, Mark S. Cragg, Frank J. Ward and Lekh N. Dahal
Type: Article
| 2023
Agonist antibodies for cancer immunotherapy: History, Hopes and Challenges - Sean H. Lim, Stephen A. Beers, Aymen Al-Shamkhani and Mark S. Cragg
Type: Article
| 2023
| Item availability restricted.
Towards a better understanding of human iNKT cell subpopulations for improved clinical outcomes - Alex Look, Daniel Burns and Ivo Tews
Type: Review
| 2023
Development of C1q affinity chromatography for the study of C1q-IgG interactions - Michael J.E. Marshall, Alexander Knaupp, Christian Spick, Ilker Koese, Maria Maier, Mark S. Cragg, Florian Cymer and Tilman Schlothauer
Type: Article
| 2023
Effect of posttranslational modifications and subclass on IgG activity: From Immunity to Immunotherapy - Falk Nimmerjahn, Gestur Vidarsson and Mark Cragg
Type: Article
| 2023
Human leukocyte immunoglobulin-like receptors in health and disease - Silvia Redondo-García, Christopher Barritt, Charys Papagregoriou, Muchaala Yeboah, Björn Frendeus, Mark S. Cragg and Ali Roghanian
Type: Review
| 2023
The Role of mitotic slippage in creating a “female pregnancy-like system” in a single polyploid giant cancer cell - Kristine Salmina, Ninel M. Vainshelbaum, Madara Kreishmane, Inna Inashkina, Mark Cragg, Dace Pjanova and Jekaterina Erenpreisa
Type: Article
| 2023
Obesity is associated with immunometabolic changes in adipose tissue that may drive treatment resistance in breast cancer: immune-metabolic reprogramming and novel therapeutic strategies - Constantinos Savva, Ellen Copson, Peter W.M. Johnson, Ramsey I. Cutress and Stephen A. Beers
Type: Review
| 2023
Reducing affinity as a strategy to boost immunomodulatory antibody agonism - Xiaojie Yu, Christian Orr, H.T. Claude Chan, Sonya James, Christine A. Penfold, Jinny Kim, Tatyana Inzhelevskaya, C. Ian Mockridge, Kerry L. Cox, Jonathan W. Essex, Ivo Tews, Martin J. Glennie and Mark S. Cragg
Type: Article
| 2023
Zwitterionic targeting Doxorubicin - loaded micelles assembled by amphiphilic dendrimers with enhanced antitumor performance - Lu Zhang, Quanling Guo, Ruixue Zheng, Qingyu Yu, Ying Liang, Guanglong Ma, Qiurong Li, Xiaoyu Zhang, Haiyan Xiao and Longgang Wang
Type: Article
| 2023